Inhibiting this miRNA allowed neuronal protection in an in vitro AD cell model by targeting neuregulin-1 (NRG1), which plays an essential role in enhancing cellular oxidative capacity by controlling PGC-1α-mediated mitochondrial biogenesis [72,73]. The gene discussed is NRG1; the disease is Alzheimer disease.